Let’s get this out of the way first: Amazon’s acquisition of PillPack could dramatically shake up the U.S. pharmacy industry and change the way Americans purchase prescription drugs.
But the announcement of this deal is the first step on a long and crooked path, and there is no guarantee that Amazon (AMZN), for all its size and success, will quickly become a major player in the nation’s $370 billion drug business.
The acquisition of PillPack confirms Amazon’s intention to sell prescription drugs to consumers nationwide. With a primary pharmacy located in Manchester, N.H., PillPack has operations across the country and ships prescription drugs in pre-sorted packets to 49 states (the only exception being Hawaii).
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.